Bio-Technology General Israel (BTG) is a company specializing in the development and manufacture of human healthcare products derived from genetic engineering and biotechnology processes. With a successful track record of developing and registering biopharmaceuticals, BTG invests heavily in research and development, collaborating with scientific institutes and partnering with biotechnology and pharmaceutical companies worldwide. The company has a focus on therapeutic areas such as reproductive health, endocrinology, orthopedics, and ophthalmology. BTG operates a 10,000 square meter cGMP manufacturing facility and a 1,900 square meter development wing, employing around 300 experts. Their management philosophy emphasizes corporate social responsibility, environmental health and safety policies, and they take pride in engaging with local communities around their site. BTG is associated with Ferring Pharmaceuticals and is committed to excellence in its field, striving to improve human lives through its expertise in biotechnology.